Načítá se...
The making and function of CAR cells
Genetically engineered T cells expressing chimeric antigen receptors (CAR) present a new treatment option for patients with cancer. Recent clinical trials of B cell leukemia have demonstrated a response rate of up to 90%. However, CAR cell therapy is frequently accompanied by severe side effects suc...
Uloženo v:
| Vydáno v: | Immunol Lett |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7058416/ https://ncbi.nlm.nih.gov/pubmed/31181279 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.imlet.2019.06.002 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|